Sanmina

Sanmina focuses on high-complexity, medium-volume production for regulated industries — medical devices, defense systems, and telecom infrastructure — rather than consumer electronics. This requires deep co-engineering with clients during product development and sustained regulatory compliance. The result is longer product lifecycles and lower customer churn than in consumer-focused EMS firms.

Sanmina's Defense and Aerospace segment manufactures secure communications equipment, radar systems, and electronic warfare components for the U.S. Department of Defense and allied governments. The firm holds necessary facility security clearances to produce classified hardware, a barrier to entry that limits competition in this segment. The division accounted for a growing share of revenue as of fiscal 2024 (per company filings).

In May 2023, Sanmina formed a joint venture with Reliance Strategic Business Ventures to build a large-scale electronics manufacturing hub in Chennai. The move aligned with India's production-linked incentive (PLI) scheme, which subsidizes domestic hardware production for telecom and IT. The JV positions Sanmina to capture growth from both Indian domestic demand and global OEMs seeking China-plus-one supply chain diversification (per company announcement, May 2023).

Jure Sola has served as CEO since co-founding Sanmina in 1980, a rare four-decade-plus tenure in public technology manufacturing. He combines the chairman and CEO roles, giving him significant control over capital allocation and strategy. While this stability benefits long-term customer relationships in slow-cycle industrial markets, it also concentrates governance risk in a single individual with no publicly designated succession plan.

Sanmina produces surgical robotics subassemblies, diagnostic imaging components, and Class II and III medical devices requiring FDA-compliant manufacturing. The firm provides design-for-manufacturability engineering, sterilization management, and supply chain traceability for medtech OEMs. Known customers include Medtronic, for whom Sanmina manufactures robotic surgery platforms (per company disclosures).

Sanmina owns proprietary component technologies — including optical transceivers, high-speed backplanes, and precision machined enclosures — sold directly into OEM supply chains. This mixes recurring component revenue with the project-based nature of contract manufacturing, creating a margin profile distinct from pure build-to-print EMS firms. The component portfolio also serves as a client acquisition channel, pulling through integrated manufacturing deals.

Sanmina operates over 80 facilities in 25 countries, with major manufacturing campuses in the United States, Mexico, China, Malaysia, Thailand, and India. This geographic breadth reduces single-country overconcentration compared to EMS peers heavily weighted toward China. The 2023 Reliance JV in India further diversifies the footprint, aligning with OEM demand for supply chain resilience in previously underserved regions.